Stay updated with breaking news from Ian Meredith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As part of a mini-series exploring arbitration in Asia, Ian Meredith (K&L Gates, London) speaks with Dr. Mingchao Fan, the Executive Vice President of the Shanghai Arbitration...
Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty
Nearly a quarter of the way through 2023, we've seen plenty of movement in the personnel department across medtech.
Dr. Ian Meredith, an interventional cardiologist with 35+ years of experience, has joined Avertix Medical's board of directors.
Boston Scientific's new global chief medical officer is already well-known in cardiovascular device space circles.